Doxil
Links shared publicly online about this topic
Oral COTI-2 Plus Doxil(R) Is Superior To Doxil Alone In An Animal Model Of Human Ovarian Cancer
medicalnewstoday.com — “Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT) announced important positive results today from a series of experiments carried out at a prominent American cancer research facility. Th” View full resource at medicalnewstoday.com
Most Recently Shared on January 24, 2010 at 2:44 am By:
MNT Women's Health Health News
Oral COTI-2 Plus Doxil(R) Is Superior To Doxil Alone In An Animal Model Of Human Ovarian Cancer: Critical Outcom.. http://bit.ly/yfuaZ
Johnson & Johnson Warns of Doxil (doxorubicin) Shortage - QualityPoint Technologies
qualitypointtech.net — “Johnson & Johnson has cautioned doctors not to start patients on therapy with its Doxil (doxorubicin Hcl liposome injection) because of shortages of the medicine made by an outside manufacturer. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on July 22, 2011 at 9:00 pm By:
Johnson & Johnson Warns of Doxil (doxorubicin) Shortage: Johnson & Johnson has cautioned doctors not to start ... http://bit.ly/raOoxN
FDA issues complete response letter to NDA for trabectedin combined with Doxil - MPR
empr.com — “Centocor Ortho Biotech Products (a division of Johnson & Johnson) announced that it received a complete response letter from the FDA regarding the New Drug Application (NDA) for trabectedin in combination with Doxil (doxorubicin HCI liposome injection) for the treatment of relapsed ovarian cancer.” View full resource at empr.com
Most Recently Shared on September 10, 2009 at 7:40 pm By:
MPR News: FDA issues complete response letter to NDA for trabectedin combined with Doxil: Centocor Orth.. http://bit.ly/1bBDyF
FDA Issues Complete Response Letter for Trabectedin Combined With DOXIL
jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.” View full resource at jnj.com
Most Recently Shared on September 10, 2009 at 7:22 pm By:
eyeonfda Pharma and Health Lawyer
FDA Issues Complete Response Letter for Trabectedin Combined With DOXIL http://bit.ly/PnBfh
The Personal Price Paid for Shortages of Doxil and Other Drugs - NYTimes.com
nytimes.com — “Production problems have disrupted treatment plans. Experts advise patients to take a number of practical steps.” View full resource at nytimes.com
Most Recently Shared on December 13, 2011 at 3:20 pm By:
Mary Sue McAslan PharmD, Doctor, and Pharmacist
The Personal Price Paid for Shortages of Doxil and Other Drugs: http://t.co/5dcKJkbM
The Personal Price Paid for Shortages of Doxil and Other Drugs - NYTimes.com
nytimes.com — “Production problems have disrupted treatment plans. Experts advise patients to take a number of practical steps.” View full resource at nytimes.com
Most Recently Shared on December 13, 2011 at 10:39 am By:
Strataderm for Scars Pharma and Health Social Media
The Personal Price Paid for Shortages of Doxil and Other Drugs: http://t.co/cYiNJON0 #health #cancer
The Personal Price Paid for Shortages of Doxil and Other Drugs - NYTimes.com
nytimes.com — “Production problems have disrupted treatment plans. Experts advise patients to take a number of practical steps.” View full resource at nytimes.com
Most Recently Shared on December 12, 2011 at 11:49 pm By:
Stephen Meyers, MD Doctor, Family Medicine Doctor, and Physician
The Consumer: The Personal Price Paid for Shortages of Doxil and Other Drugs http://t.co/Qghhmjcu RT @healthcare_wire
The Personal Price Paid for Shortages of Doxil and Other Drugs - NYTimes.com
nytimes.com — “Production problems have disrupted treatment plans. Experts advise patients to take a number of practical steps.” View full resource at nytimes.com
Most Recently Shared on December 16, 2011 at 7:35 pm By:
Drug Scarcity’s Dire Cost, & Some Ways to Cope (NY Times) http://t.co/BLggV9yz (ASHP in the News)
The Personal Price Paid for Shortages of Doxil and Other Drugs - NYTimes.com
nytimes.com — “Production problems have disrupted treatment plans. Experts advise patients to take a number of practical steps.” View full resource at nytimes.com
Most Recently Shared on December 14, 2011 at 6:38 pm By:
@nytimes examines the impact of drug shortages on patients, physicians and hospitals: http://t.co/JyQQXBVL RT @daily_briefing
The Personal Price Paid for Shortages of Doxil and Other Drugs - NYTimes.com
nytimes.com — “Production problems have disrupted treatment plans. Experts advise patients to take a number of practical steps.” View full resource at nytimes.com
Most Recently Shared on December 14, 2011 at 9:21 pm By:
Dr. P. D Tapp Doctor, Health Executive, and PhD
The Personal Price Paid for Shortages of Cancer Drugs http://t.co/NQDowNKA
The Personal Price Paid for Shortages of Doxil and Other Drugs - NYTimes.com
nytimes.com — “Production problems have disrupted treatment plans. Experts advise patients to take a number of practical steps.” View full resource at nytimes.com
Most Recently Shared on December 13, 2011 at 2:14 pm By:
Brandon Hayes-Lattin Doctor, Internist, Oncologist, and Physician
The NYT consumer reports "Drug Scarcity’s Dire Cost, and Some Ways to Cope" http://t.co/lGdNkMjz
Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) For The Treatment Of Advanced Breast Cancer
medicalnewstoday.com — “Centocor ortho biotech products, l.p. announced that it received a complete response letter from the u.s. food and drug administration (fda) regarding its supplemental new drug application (snda) ” View full resource at medicalnewstoday.com
Most Recently Shared on September 11, 2009 at 3:04 pm By:
Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) For The Treatment Of Advanced Br.. http://bit.ly/4obcLd
J&J Drops Development Of Doxil As Breast Cancer Treatment - WSJ.com
online.wsj.com — “J&J Drops Development Of Doxil As Breast Cancer Treatment - WSJ.com” View full resource at online.wsj.com
Most Recently Shared on May 25, 2010 at 9:11 pm By:
Komen Sacramento Health Organization
J&J Drops Development Of Doxil As Breast Cancer Treatment http://ht.ly/1POuh
Supplier Of J&J Cancer Drug Doxil Halts Manufacturing At Ohio Plant - WSJ.com
online.wsj.com — “Supplier Of J&J Cancer Drug Doxil Halts Manufacturing At Ohio Plant - WSJ.com” View full resource at online.wsj.com
Most Recently Shared on November 22, 2011 at 5:43 am By:
Paul Cacciatore Patient Advocate
Supplier Of J&J (Ovarian) Cancer Drug Doxil Halts Manufacturing At Ohio Plant. (WSJ) http://t.co/4Y8u812T
A life and death wait for Doxil, a cancer weapon in short supply | The Courier-Journal | courier-journal.com
courier-journal.com — “Barry Norris was relieved and encouraged when a chemotherapy drug called Doxil shrunk a painful, disabling cancerous lesion on his foot to half its size. But when he arrived at the James Graham Brown Cancer Center in late August for a treatment, he was told there was no more Doxil available because of a nationwide shortage.” View full resource at courier-journal.com
Most Recently Shared on September 22, 2011 at 12:29 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
A life and death wait for Doxil, a cancer weapon in short supply | The Courier-Journal | courier-journal.com http://t.co/Z1Se8WNw
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Women's Health
The latest women's health and gynecology news published daily. Articles from research centers, universities and prestigious journals.
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
